[ad_1] ICON Public (NASDAQ:ICLR – Free Report) had its target price decreased by Barclays from $355.00 to $350.00 in a report issued on Friday morning, Benzinga...
[ad_1] Icon PLC ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical...